Vaccine development for HIV infection.
Publication
, Journal Article
Bolognesi, D
Published in: J Am Acad Dermatol
June 1990
The immune response that develops subsequent to infection with human immunodeficiency virus (HIV) consists of both humoral and cellular elements that, when tested in vitro, can inhibit virus infection and syncytium formation and lyse virus-infected target cells. The antiviral immune response may thus represent one of the primary host-defense mechanisms responsible for the protracted asymptomatic phase of the disease that, in most patients, can last several years. An important question to be answered in the development of vaccine strategies against HIV is whether this response might be an effective barrier to de novo HIV infection.
Duke Scholars
Published In
J Am Acad Dermatol
DOI
ISSN
0190-9622
Publication Date
June 1990
Volume
22
Issue
6 Pt 2
Start / End Page
1295 / 1299
Location
United States
Related Subject Headings
- Viral Vaccines
- Humans
- HIV Infections
- HIV Antigens
- HIV Antibodies
- HIV
- Genetic Variation
- Drug Evaluation
- Drug Design
- Dermatology & Venereal Diseases
Citation
APA
Chicago
ICMJE
MLA
NLM
Bolognesi, D. (1990). Vaccine development for HIV infection. J Am Acad Dermatol, 22(6 Pt 2), 1295–1299. https://doi.org/10.1016/0190-9622(90)70176-i
Bolognesi, D. “Vaccine development for HIV infection.” J Am Acad Dermatol 22, no. 6 Pt 2 (June 1990): 1295–99. https://doi.org/10.1016/0190-9622(90)70176-i.
Bolognesi D. Vaccine development for HIV infection. J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1295–9.
Bolognesi, D. “Vaccine development for HIV infection.” J Am Acad Dermatol, vol. 22, no. 6 Pt 2, June 1990, pp. 1295–99. Pubmed, doi:10.1016/0190-9622(90)70176-i.
Bolognesi D. Vaccine development for HIV infection. J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1295–1299.
Published In
J Am Acad Dermatol
DOI
ISSN
0190-9622
Publication Date
June 1990
Volume
22
Issue
6 Pt 2
Start / End Page
1295 / 1299
Location
United States
Related Subject Headings
- Viral Vaccines
- Humans
- HIV Infections
- HIV Antigens
- HIV Antibodies
- HIV
- Genetic Variation
- Drug Evaluation
- Drug Design
- Dermatology & Venereal Diseases